CurveBeam Connect: Dr. Alireza Khosroabadi’s True “Minimally Invasive” Bunion Procedure

 

Dr. Alireza Khosroabadi, DPM, opened the Khosroabadi Institute for Advanced Minimally Invasive Foot & Ankle Surgery in Los Angeles, CA to focus strictly on surgical procedures.

His self-developed minimally invasive bunion procedure has been featured on “The Doctors” television show. Dr. Khosroabadi spoke to CuveBeam’s Vinti Singh about this procedure and other surgeries performed at his institute.

Dr. Khosbroabadi’s trademarked AMI (advanced minimally invasive) bunion procedure was something he started performing about six years ago.

“This procedure is similar to one common in Europe,” Dr. Khosbroabadi said. He refined it overtime, and can now perform the bunion correction in less than 25 minutes. Seeing a rise in the medical community utilizing the term “minimally invasive” loosely, Dr. Khosbroabadi trademarked the AMI procedure to protect this type of surgery’s integrity.

In Dr. Khosroabadi’s approach towards bunion procedures, he strives to realign the joint without removing any excess bone. In 98% of Dr. Khosroabadi’s patient’s cases, shaving the bunion down isn’t necessary.

One of the things Dr. Khosroabadi invested in for his institute is CT weight-bearing imaging.

“All my patients, anyone going under the knife in my surgery center, gets weight-bearing CT imaging,” Dr. Khosroabadi said. “I felt the regular, 2D X-ray wasn’t good enough for me to assess everything that I wanted to assess. Also, it would take a little longer for me to obtain the images I wanted.”

To learn more about Dr. Khosroabadi & the Khosroabadi Institute, visit https://www.877foot911.com/.

Follow us on social media for the latest updates in B2B!

Twitter – @MarketScale
Facebook – facebook.com/marketscale
LinkedIn – linkedin.com/company/marketscale

Recent Episodes

In this impactful episode of the ConCensis podcast, host Yasmeen Hassan sits down with Robby Miller, Sterile Processing Manager at St. Joseph’s Hospital Medical Center, to explore how artificial intelligence is revolutionizing the field of sterile processing. With nearly 30 years of experience in healthcare, Miller shares his journey from EMT to SPD leader, offering…

In the last two decades, oncology has undergone a transformation with over 300 new cancer therapies approved by the FDA—many offering novel mechanisms of action. Despite these innovations, resistance to treatment remains a critical challenge, with cancer cells evolving or adapting to evade even the most advanced therapeutics. This issue is particularly pressing given that…

In an era where precision and predictability define the future of oncology, organoid technology is emerging as a transformative tool in drug discovery. These miniature, lab-grown 3D tissues mirror real human biology more closely than traditional 2D models or even animal systems, offering researchers the potential to predict patient-specific drug responses. As organoids become more…